Sun Wei, Tang HaiYing, Gao Lili, Sun Xiuna, Liu Jia, Wang WeiDong, Wu Taihua, Lin Hongli
Departments of Respiratory Medicine, The First Affiliated Hospital of Dalian Medical University, 222# Zhongshan Road, Dalian, Liaoning 116011, PR China.
Departments of Nephrology, The First Affiliated Hospital of Dalian Medical University, 222# Zhongshan Road, Dalian, Liaoning 116011, PR China.
Int J Biochem Cell Biol. 2017 Jul;88:44-54. doi: 10.1016/j.biocel.2017.05.010. Epub 2017 May 5.
Pulmonary fibrosis is a common outcome of a variety of pulmonary interstitial diseases, and myofibroblasts are the main culprit for this process. Recent studies have found that pericytes are one of the major sources of myofibroblasts; the transformation of which involves a complex process of activation of TGF-β/Smad2/3 and PDGFβ/Erk signaling pathways. We have reported that the transforming growth factor-β receptor and platelet-derived growth factor-β receptor (TGF-βR I and PDGFβR, respectively) are modified by glycosylation. Thus, we hope to regulate the above-mentioned signal pathways through core fucosylation (CF) catalyzed by α-1,6-fucosyltransferase (FUT8). Previous work has confirmed that TGF-β1 can induce the transformation of pericytes into myofibroblasts, while FUT8siRNA can inhibit such transformation. In the present study, we used an adenovirus packaging FUT8 shRNA to infect a bleomycin-induced pulmonary fibrosis mouse model and determined the effect of CF on pulmonary fibrosis by analyzing the mechanism of CF-mediated pericyte transformation. Our findings may shed new light on the mechanism of pulmonary interstitial fibrosis and provide a novel therapeutic target for clinical applications.
肺纤维化是多种肺间质疾病的常见结局,而成肌纤维细胞是这一过程的主要元凶。最近的研究发现,周细胞是成肌纤维细胞的主要来源之一;其转化涉及TGF-β/Smad2/3和PDGFβ/Erk信号通路激活的复杂过程。我们曾报道,转化生长因子-β受体和血小板衍生生长因子-β受体(分别为TGF-βR I和PDGFβR)会发生糖基化修饰。因此,我们希望通过α-1,6-岩藻糖基转移酶(FUT8)催化的核心岩藻糖基化(CF)来调节上述信号通路。先前的研究证实,TGF-β1可诱导周细胞转化为成肌纤维细胞,而FUT8siRNA可抑制这种转化。在本研究中,我们使用包装有FUT8 shRNA的腺病毒感染博来霉素诱导的肺纤维化小鼠模型,并通过分析CF介导的周细胞转化机制来确定CF对肺纤维化的影响。我们的研究结果可能为肺间质纤维化的机制提供新的见解,并为临床应用提供新的治疗靶点。